The MID of 9 amino acids and trehalose were reported. Three "S" type reactions were included in the metabolite network to directly map label distribution of alanine, aspartate and glutamate to pyruvate, oxaloacetate and α-ketoglutarate, respectively. This was not necessary for all other amino acids and trehalose because these metabolites were already described in the isotopomer balances.
Oxaloacetate
This four-carbon dicarboxylic acid serves as a substrate for the enzyme malate dehydrogenase, enabling the reversible conversion between oxaloacetate and malate.
Oxaloacetate is also involved in gluconeogenesis, amino acid synthesis, and other vital biochemical processes.
Understainding the regulation and dynamics of oxaloacetate is essential for researchers studying cellular energetics, metabolic disorders, and potential therapeutic interventions targeting these pathways.
PubCompare.ai offers a powerful AI-driven platform to optimize oxloacetae research by locating the most reliable protocols from literature, preprints, and patents, while providing accurate comparisons to identify the best experimental options.
Enhance your research reproducibiltiy and accuracy with the tools availabe on PubCompare.ai.
Most cited protocols related to «Oxaloacetate»
The MID of 9 amino acids and trehalose were reported. Three "S" type reactions were included in the metabolite network to directly map label distribution of alanine, aspartate and glutamate to pyruvate, oxaloacetate and α-ketoglutarate, respectively. This was not necessary for all other amino acids and trehalose because these metabolites were already described in the isotopomer balances.
We calculated the [2-13C]malate enrichment by relating the positional enrichments of malate to those measured in glutamate assuming (and validating) full equilibration across fumarase as shown in
For calculation of the liver-specific metabolic flux ratio VPyr-Cyc/VMito = (VPK + VME, out)/(VPC + VME, in+ VPDH), we used our previously published isotopic labeling model (6 (link), 7 (link)) extended using a mass isotopomer multiordinate spectral analysis approach to take into account VPK and unlabeled mass entry from propionate at the succinyl-CoA step of the TCA cycle (10 (link)). Here, VME, out refers to ME flux in the direction of pyruvate synthesis; VME, in refers to the reverse reaction of pyruvate into malate, and VLDH refers to pyruvate synthesis via LDH. With these fluxes taken into account, we can describe the steady-state mass balance at pyruvate with
and isotope balance at [2-13C]pyruvate with
Because the positional enrichments of pyruvate and PEP cannot be measured reliably using our NMR-LC-MS/MS techniques, we use the following label substitutions shown in
Substituting
By separating out like terms, we get
where VPDH denotes flux through pyruvate dehydrogenase; VCS denotes flux through citrate synthase; VPK denotes flux through pyruvate kinase; VME, out denotes flux through malic enzyme from malate to pyruvate; VME, in denotes flux through malic enzyme from pyruvate to malate; and VPC denotes flux through pyruvate carboxylase. Additional fluxes shown in the complete flux diagram in
The fraction of cytosolic oxaloacetate originating from cytosolic pyruvate is given by:
Most recents protocols related to «Oxaloacetate»
Example 2
A 28 year-old woman experienced severe anger and depression one day a month, right before her period, every month. She took two capsules of 100 mg anhydrous enol-oxaloacetate on that day. She reported that while the anger and depression were not completely resolved, they were reduced in intensity to the point where she could manage the symptoms easily.
Example 1
In a clinical trial, 30 women with PMS were first evaluated for PMS and then presented with the nutritional supplement “benaGene” (100 mg anhydrous enol-oxaloacetate with a pharmaceutically acceptable excipient of 150 mg anhydrous ascorbic acid). Only one patient did not report a substantial improvement, indicative of a positive response rate of 97%. Typically, in 30-60 minutes from taking 1 to 2 capsules, once per day, many or all PMS symptoms would either resolve fully or would be reduced significantly. The patients would only take the supplement during days they experienced PMS symptoms, and not the rest of the month. 3 capsules did not produce a superior response to 2 capsules.
Example 6
A 25-year old woman presented with severe anxiety attacks and fatigue during the week before menstruation. At the start of these panic attacks or during extreme fatigue, she placed two lozenges of 100 mg anhydrous enol-oxaloacetate with a suitable pH adjustment and pharmaceutical carrier under her tongue for 5 minutes. The panic attack subsided in less than 5 minutes and fatigue was greatly reduced.
Example 5
A woman presented with severe PMDD ever since she was 13 years old. She is now 26. Typically, the patient had to take-off from work 3 days out of each month, and self-seclude, because she could not be with people. She started taking 2 capsules benaGene (each 100 mg anhydrous enol-oxaloacetate with acceptable pharmacological carriers). All symptoms resolved and she no longer has to take off from work. The improvements with anhydrous enol-oxaloacetate have continued for over 2 years with this patient.
Top products related to «Oxaloacetate»
More about "Oxaloacetate"
This four-carbon dicarboxylic acid serves as a substrate for the enzyme malate dehydrogenase, enabling the reversible conversion between oxaloacetate and malate.
Oxaloacetate is also involved in gluconeogenesis, amino acid synthesis, and other essential biochemical processes.
Understanding the regulation and dynamics of oxaloacetate is essential for researchers studying cellular energetics, metabolic disorders, and potential therapeutic interventions targeting these pathways.
Pyruvate, another key metabolite, is closely linked to oxaloacetate as it can be converted to oxaloacetate via the anaplerotic reaction catalyzed by pyruvate carboxylase.
Malate, a related compound, can also be interconverted with oxaloacetate through the action of malate dehydrogenase.
Alpha-ketoglutarate, another citric acid cycle intermediate, is related to oxaloacetate through its involvement in amino acid metabolism and anaplerotic pathways.
D-2-hydroxyglutarate, a metabolite that can accumulate in certain disease states, may also interact with oxaloacetate-related pathways.
Protease inhibitor cocktails, commonly used in biochemical experiments, can help stabilize oxaloacetate and other metabolites.
The SpectraMax Plus 384 is a versatile microplate reader that can be utilized to measure oxaloacetate and related metabolites.
L-malate and D-malate are stereoisomers of malate that can influence oxaloacetate dynamics.
Optimizing oxaloacetate research is crucial, and PubCompare.ai offers a powerful AI-driven platform to locate the most reliable protocols from literature, preprints, and patents, while providing accurate comparisons to identify the best experimental options.
Enhance your research reproducibility and accuracy with the tools available on PubCompare.ai.